Live symbol workspace

JNJ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $243.04

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$230.89

Resistance

$255.19

Volume & Momentum

Volume

Normal

1.0x avg

Momentum

0%

Weak

Technical Context

Current price

$243.04

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for JNJ skewed neutral (5 of 6 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

31%

▼ 3.2 pts vs previous week

Avg confidence across 41 calls in the last 7 days

What sources say

Neutral 5 articles

Ebola Crisis Exposes Congo's Fragile Health System

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Why Is JNJ Stock Defying The Market’s Daily Mood Swings?

Bearish 1 article

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

JNJ News Intelligence (24 articles)

AI-curated news influencing JNJ price, sentiment, and trend

Explore All JNJ News with AI Analysis

Economy

2 months, 4 weeks ago

Better Buy Right Now: Johnson & Johnson Vs. Pfizer

The choice is based on more than just the dividend payout.

Impact on JNJ: Insufficient data to determine direct market consequences, but a positive or negative …

The article compares Johnson & Johnson and Pfizer as investment options, considering factors beyond dividend … Low (20%)

View full analysis →

Yahoo Finance 20% confidence

Economy

2 months, 4 weeks ago

Japan to Work With Asian Nations to Ease Oil Bottleneck: Akazawa

Japan will work closely with Asian countries where essential petroleum-based products including medical equipment are produced, economy minister Ryosei Akazawa …

Impact on JNJ: The news may lead to a decrease in oil prices and a …

Japan's economy minister announced plans to collaborate with Asian nations to alleviate oil supply chain … High (70%)

View full analysis →

Bloomberg 70% confidence

Economy

3 months, 2 weeks ago

Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now

AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation.

Impact on JNJ: AbbVie's (ABBV) undervaluation could lead to a price increase, potentially driving the …

AbbVie's strong financials, attractive dividend, and modest valuation make its stock appear undervalued, presenting a … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Stocks

3 months, 2 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease …

Impact on JNJ: The announcement is likely to have a positive impact on Pfizer's (PFE) …

Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine after a … High (80%)

View full analysis →

MarketWatch 80% confidence

Economy

3 months, 3 weeks ago

2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow

This stock is one to own during any market environment.

Impact on JNJ: The article is unlikely to have a significant impact on JNJ's stock …

The article suggests Johnson & Johnson (JNJ) stock is a stable investment for any market … Low (20%)

View full analysis →

Yahoo Finance 20% confidence

Economy

3 months, 3 weeks ago

Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move

These companies are benefiting from a tidal wave of demand for new weight-loss drugs.

Impact on JNJ: The increased demand for weight-loss drugs could lead to a surge in …

The recent surge in demand for new weight-loss drugs is expected to benefit top S&P … High (70%)

View full analysis →

Yahoo Finance 70% confidence